21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
01.28.Z - Cultivation of spice, aromatic plants and plants used for pharmaceuticals
10.41.Z - Production of oils and other liquid fats
10.89.Z - Production of other food products, not elsewhere classified
20.53.Z - Manufacture of chemicals and chemical products
21.10.Z - Manufacture of basic pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.29.Z - Retail trade
47.73.Z - Retail sale of pharmaceutical products
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,3 | -0,1 | -0,3 | -188,3 |
EBITDA | -0,3 | -0,1 | -0,2 | -164,3 |
Short time liabilities | 0,3 | 0,3 | 0,9 | 182,6 |
Equity capital | 0 | -0 | -0,3 | -689,5 |
Operating profit (EBIT) | -0,3 | -0,1 | -0,2 | -193,8 |
Assets | 0,3 | 0,5 | 1,5 | 195,6 |
Net profit (loss) | -0,3 | -0,1 | -0,3 | -188,3 |
Cash | 0 | 0 | 0,4 | 1105,6 |
Net income from sale | 0 | 0,1 | 0 | -100 |
Liabilities and provisions for liabilities | 0,3 | 0,5 | 1,8 | 229,6 |
Working assets | 0,3 | 0,1 | 0,7 | 939 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | -751,7 | 239,2 | 87,3 | -151,9 |
Equity capital to total assets | 13,1 | -7,4 | -19,7 | -12,3 |
Gross profit margin | -2088,6 | -139,5 | 1949,1 | |
EBITDA Margin | -2078,7 | -120,7 | 1958 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 6726 | 1917 | 2 147 483 648 | 2 147 481 731 |
Current financial liquidity indicator | 1.150789499282837 | 0.19735920429229736 | 0.5354830622673035 | 0,3 |
Net dept to EBITDA | -0.46232137084007263 | -6.259901523590088 | -5.097049713134766 | 1,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane